Julia von Tresckow

2.8k total citations
35 papers, 391 citations indexed

About

Julia von Tresckow is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Julia von Tresckow has authored 35 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 26 papers in Pathology and Forensic Medicine and 16 papers in Immunology. Recurrent topics in Julia von Tresckow's work include Chronic Lymphocytic Leukemia Research (29 papers), Lymphoma Diagnosis and Treatment (26 papers) and Immunodeficiency and Autoimmune Disorders (15 papers). Julia von Tresckow is often cited by papers focused on Chronic Lymphocytic Leukemia Research (29 papers), Lymphoma Diagnosis and Treatment (26 papers) and Immunodeficiency and Autoimmune Disorders (15 papers). Julia von Tresckow collaborates with scholars based in Germany, United States and Ukraine. Julia von Tresckow's co-authors include Barbara Eichhorst, Michael Hallek, Jasmin Bahlo, Kirsten Fischer, Paula Cramer, Stephan Stilgenbauer, Petra Langerbeins, Matthias Ritgen, Clemens‐Martin Wendtner and Sandra Robrecht and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Julia von Tresckow

30 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia von Tresckow Germany 9 333 303 128 92 58 35 391
Magdalena Piotrowska Poland 4 429 1.3× 400 1.3× 222 1.7× 84 0.9× 58 1.0× 7 536
Ilya Zyuzgin Russia 3 323 1.0× 301 1.0× 149 1.2× 59 0.6× 49 0.8× 7 364
Richard F Schlenk Germany 5 312 0.9× 252 0.8× 159 1.2× 62 0.7× 52 0.9× 5 368
Moiseev Si Russia 4 393 1.2× 348 1.1× 181 1.4× 101 1.1× 59 1.0× 14 452
Thérèse Aurran France 8 202 0.6× 178 0.6× 80 0.6× 40 0.4× 23 0.4× 19 257
Silvia Finotto Italy 10 166 0.5× 186 0.6× 39 0.3× 43 0.5× 32 0.6× 18 291
Manuela A. Bergmann Germany 6 562 1.7× 502 1.7× 239 1.9× 104 1.1× 96 1.7× 11 592
R. F. Bezares Argentina 3 516 1.5× 438 1.4× 250 2.0× 97 1.1× 86 1.5× 5 555
Claes Karlsson Sweden 9 260 0.8× 199 0.7× 169 1.3× 117 1.3× 24 0.4× 19 399
Abigail S. Kelliher United States 7 178 0.5× 161 0.5× 95 0.7× 135 1.5× 16 0.3× 9 369

Countries citing papers authored by Julia von Tresckow

Since Specialization
Citations

This map shows the geographic impact of Julia von Tresckow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia von Tresckow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia von Tresckow more than expected).

Fields of papers citing papers by Julia von Tresckow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia von Tresckow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia von Tresckow. The network helps show where Julia von Tresckow may publish in the future.

Co-authorship network of co-authors of Julia von Tresckow

This figure shows the co-authorship network connecting the top 25 collaborators of Julia von Tresckow. A scholar is included among the top collaborators of Julia von Tresckow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia von Tresckow. Julia von Tresckow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tresckow, Julia von, et al.. (2024). Single-cell analysis of a bi-clonal chronic lymphocytic leukemia reveals two clones with distinct gene expression pattern. Leukemia & lymphoma. 66(4). 744–752. 1 indexed citations
3.
Knoll, Maximilian, Deyan Y. Yosifov, Christof Schneider, et al.. (2024). Biallelic Deletion 13q in Chronic Lymphocytic Leukemia Treated with Targeted Agents. Blood. 144(Supplement 1). 4608–4608.
4.
5.
Mohr, Christopher, Patricia Johansson, Anja Eckstein, et al.. (2023). MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy: imaging remission criteria and volumetric regression kinetics. Scientific Reports. 13(1). 4792–4792. 1 indexed citations
6.
Tresckow, Julia von, Sandra Robrecht, Ali Aldaoud, et al.. (2023). Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group. Annals of Hematology. 102(11). 3083–3090. 4 indexed citations
7.
Bechrakis, Nikolaos E., Anja Eckstein, Henrike Westekemper, et al.. (2022). Long‐term follow‐up and health‐related quality of life among cancer survivors with stage IEA orbital‐type lymphoma after external photon‐beam radiotherapy: Results from a longitudinal study. Hematological Oncology. 40(5). 922–929. 2 indexed citations
8.
Schilhabel, Anke, Paula Cramer, Julia von Tresckow, et al.. (2022). CD20 Expression as a Possible Novel Prognostic Marker in CLL: Application of EuroFlow Standardization Technique and Normalization Procedures in Flow Cytometric Expression Analysis. Cancers. 14(19). 4917–4917. 3 indexed citations
9.
Cramer, Paula, Eugen Tausch, Julia von Tresckow, et al.. (2021). Durable remissions following combined targeted therapy in patients with CLL harboring TP53 deletions and/or mutations. Blood. 138(19). 1805–1816. 6 indexed citations
10.
Tresckow, Julia von, Bastian von Tresckow, Hans Christian Reinhardt, Ken Herrmann, & Christoph Berliner. (2021). Thymic hyperplasia after mRNA based Covid-19 vaccination. SHILAP Revista de lepidopterología. 16(12). 3744–3745. 5 indexed citations
11.
Simon, Florian, Sandra Robrecht, Anna‐Maria Fink, et al.. (2021). Pooled Analysis of First-Line Treatment with Targeted Agents in Patients with Chronic Lymphocytic Leukemia (CLL) Aged 80 Years and Older. Blood. 138(Supplement 1). 1552–1552. 1 indexed citations
12.
Cramer, Paula, Julia von Tresckow, Barbara Eichhorst, & Michael Hallek. (2020). Aktuelle Standards in der Diagnostik und Therapie der chronischen lymphatischen Leukämie. DMW - Deutsche Medizinische Wochenschrift. 145(16). 1139–1144. 1 indexed citations
13.
Cramer, Paula, Julia von Tresckow, Anna‐Maria Fink, et al.. (2020). Bendamustine Followed By Obinutuzumab and Idelalisib in Patients with Chronic Lymphocytic Leukemia (CLL): CLL2-BCG Trial of the German CLL Study Group (GCLLSG). Blood. 136(Supplement 1). 21–23. 5 indexed citations
14.
Al‐Sawaf, Othman, Sandra Robrecht, Jasmin Bahlo, et al.. (2020). Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials. Leukemia. 35(1). 169–176. 62 indexed citations
15.
Al‐Sawaf, Othman, Alexandra Bazeos, Sandra Robrecht, et al.. (2019). Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL). American Journal of Hematology. 94(9). 1002–1006. 5 indexed citations
16.
Tresckow, Julia von, Barbara Eichhorst, Jasmin Bahlo, & Michael Hallek. (2019). The Treatment of Chronic Lymphatic Leukemia. Deutsches Ärzteblatt international. 116(4). 41–46. 10 indexed citations
17.
Tresckow, Julia von, Paula Cramer, Jasmin Bahlo, et al.. (2018). CLL2-BIG: sequential treatment with bendamustine, ibrutinib and obinutuzumab (GA101) in chronic lymphocytic leukemia. Leukemia. 33(5). 1161–1172. 28 indexed citations
18.
Cramer, Paula, Julia von Tresckow, Jasmin Bahlo, et al.. (2017). BENDAMUSTINE (B), FOLLOWED BY OBINUTUZUMAB (G) AND VENETOCLAX (A) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): CLL2‐BAG TRIAL OF THE GERMAN CLL STUDY GROUP (GCLLSG). Hematological Oncology. 35(S2). 25–27. 6 indexed citations
19.
Maurer, Christian, Petra Langerbeins, Jasmin Bahlo, et al.. (2016). Effect of first-line treatment on second primary malignancies and Richter’s transformation in patients with CLL. Leukemia. 30(10). 2019–2025. 35 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magdalena Piotrowska Breakdown of academic impact, for papers by Ilya Zyuzgin Breakdown of academic impact, for papers by Richard F Schlenk Breakdown of academic impact, for papers by Moiseev Si Breakdown of academic impact, for papers by Thérèse Aurran Breakdown of academic impact, for papers by Silvia Finotto Breakdown of academic impact, for papers by Manuela A. Bergmann Breakdown of academic impact, for papers by R. F. Bezares Breakdown of academic impact, for papers by Claes Karlsson Breakdown of academic impact, for papers by Abigail S. Kelliher
Rankless by CCL
2026